Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 5.720
Filter
3.
Rev Esc Enferm USP ; 58: e20230338, 2024.
Article in English, Portuguese | MEDLINE | ID: mdl-38743957

ABSTRACT

OBJECTIVE: To map the nanocomposites used in the treatment of skin lesions. METHOD: A scoping review, according to the Joanna Briggs Institute methodology, carried out on eight databases, a list of references and Google Scholar to answer the question: "Which nanocomposites are used as a cover for the treatment of skin lesions?". Two independent reviewers selected the final sample using inclusion/exclusion criteria using the EndNote® and Rayyan programs. Data was extracted using an adapted form and reported using the PRISMA checklist extension, and the protocol was registered in the Open Science Framework (OSF). RESULTS: 21 articles were selected, with nanofibers, nanogels and nanomembranes as the nanocomposites described in wound healing, alone or in association with other therapies: negative pressure and elastic. Silver nanomaterials stand out in accelerating healing due to their antimicrobial and anti-inflammatory action, but caution should be exercised due to the risk of cytotoxicity and microbial resistance. CONCLUSION: Nanocomposites used in wound treatment are effective in accelerating healing and reducing costs, and the addition of bioactives to nanomaterials has added extra properties that contribute to healing.


Subject(s)
Nanocomposites , Skin Diseases , Wound Healing , Humans , Skin Diseases/drug therapy , Skin Diseases/therapy , Silver , Nanofibers , Anti-Infective Agents/administration & dosage
4.
Australas J Dermatol ; 65 Suppl 1: 38-41, 2024 May.
Article in English | MEDLINE | ID: mdl-38724083
5.
Br J Hosp Med (Lond) ; 85(4): 1-8, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38708977

ABSTRACT

Skin ageing is a multifaceted process impacted by both intrinsic and extrinsic factors. Drier and less elastic skin with declining sebum levels in older age makes ageing skin more vulnerable to various skin conditions, including infections, inflammatory dermatoses, and cancers. Skin problems are common among older adults due to the effects of ageing, polypharmacy and multimorbidity impacting not only physical health but wellbeing and quality of life. In the UK, older adults in geriatric medicine wards may present with various skin conditions. Hospitalised older individuals may have undiagnosed skin problems unrelated to their admission, making hospitalisation an opportunity to manage unmet needs. Asteatotic eczema, incontinence associated dermatitis, seborrhoeic dermatitis, chronic venous insufficiency, and cellulitis are common disorders clinicians encounter in the geriatric medicine wards. This article outlines the importance of performing comprehensive skin assessments to help diagnose and commence management for these common conditions.


Subject(s)
Skin Diseases , Humans , Aged , Skin Diseases/therapy , Skin Diseases/diagnosis , Skin Diseases/etiology , Skin Aging , Eczema/diagnosis , Eczema/therapy , Cellulitis/diagnosis , Cellulitis/therapy , Dermatitis, Seborrheic/therapy , Dermatitis, Seborrheic/diagnosis , Venous Insufficiency/therapy , Venous Insufficiency/complications , Venous Insufficiency/diagnosis
6.
Int J Mol Sci ; 25(8)2024 Apr 19.
Article in English | MEDLINE | ID: mdl-38674067

ABSTRACT

Photobiomodulation (PBM) is a procedure that uses light to modulate cellular functions and biological processes. Over the past decades, PBM has gained considerable attention for its potential in various medical applications due to its non-invasive nature and minimal side effects. We conducted a narrative review including articles about photobiomodulation, LED light therapy or low-level laser therapy and their applications on dermatology published over the last 6 years, encompassing research studies, clinical trials, and technological developments. This review highlights the mechanisms of action underlying PBM, including the interaction with cellular chromophores and the activation of intracellular signaling pathways. The evidence from clinical trials and experimental studies to evaluate the efficacy of PBM in clinical practice is summarized with a special emphasis on dermatology. Furthermore, advancements in PBM technology, such as novel light sources and treatment protocols, are discussed in the context of optimizing therapeutic outcomes and improving patient care. This narrative review underscores the promising role of PBM as a non-invasive therapeutic approach with broad clinical applicability. Despite the need for further research to develop standard protocols, PBM holds great potential for addressing a wide range of medical conditions and enhancing patient outcomes in modern healthcare practice.


Subject(s)
Low-Level Light Therapy , Skin , Humans , Low-Level Light Therapy/methods , Skin/radiation effects , Skin/metabolism , Animals , Skin Diseases/radiotherapy , Skin Diseases/therapy , Light , Phototherapy/methods
7.
Dermatologie (Heidelb) ; 75(5): 386-391, 2024 May.
Article in German | MEDLINE | ID: mdl-38639767

ABSTRACT

Skin diseases are complex and cannot be explained solely by genetic or environmental factors but are also significantly shaped by social influences. This review illuminates the bidirectional relationship between social factors and skin diseases, demonstrating how social determinants such as socioeconomic status, living environment, and psychosocial stress can influence the onset and progression of skin conditions. Simultaneously, it explores how skin diseases can affect individuals' social lives and work capability, leading to a cycle of social withdrawal and further deterioration of the condition. The paper describes the need for a holistic approach in dermatology that goes beyond the biomedical perspective and incorporates social factors to develop effective prevention and treatment strategies. The increasing prevalence of skin diseases in Europe and the expected rise in allergies due to climate change make the consideration of social determinants even more urgent. The findings of this review aim to raise awareness of the complex interconnections between social factors and skin health and contribute to reducing social disparities in skin health.


Subject(s)
Skin Diseases , Socioeconomic Factors , Humans , Skin Diseases/epidemiology , Skin Diseases/psychology , Skin Diseases/therapy , Social Determinants of Health , Social Factors , Risk Factors , Europe/epidemiology , Social Class , Stress, Psychological/epidemiology
8.
Dermatologie (Heidelb) ; 75(5): 366-376, 2024 May.
Article in German | MEDLINE | ID: mdl-38649555

ABSTRACT

BACKGROUND: Medical rehabilitation plays an important role in the management of patients with chronic dermatoses and dermato-oncological diseases. OBJECTIVES: Which dermatological indications qualify for a medical rehabilitation? What forms need to be completed for a successful application? Which treatments are provided and what are goals to be accomplished during dermatological rehabilitation? MATERIALS AND METHODS: Evaluation of current guidelines, directives, and recommendations as well as exemplary reviews. RESULTS: Dermato-oncological diseases and every chronic dermatological disease that is associated with a limitation of body functions and structures, activity and participation is eligible for medical rehabilitation. They include need, ability to absolve a rehabilitation, and a favorable prognosis. Treatments range from therapy of the underlying dermatological condition to interdisciplinary treatment of comorbidities with the aim of restoring functional health. CONCLUSIONS: Medical rehabilitation follows a holistic approach and represents a significant addition to outpatient and acute inpatient care, often leading to a long-term improvement in clinical outcome, participation, and activity.


Subject(s)
Dermatology , Skin Diseases , Humans , Skin Diseases/rehabilitation , Skin Diseases/therapy , Practice Guidelines as Topic , Germany , Chronic Disease/rehabilitation
9.
Article in Chinese | MEDLINE | ID: mdl-38664035

ABSTRACT

Acute skin failure (ASF) is an inevitable damage to the skin and subcutaneous tissue caused by hemodynamic instability and/or low perfusion. At present, there are some understandings and reports about adult ASF at home and abroad, but there are few reports about children's ASF. This article reviewed the definition, pathophysiological changes, risk factors, clinical manifestations, and management of children's ASF, and put forward suggestions in order to provide ideas for clinical diagnosis and treatment of children's ASF, and promote the further study of children's ASF.


Subject(s)
Skin , Humans , Child , Skin/pathology , Skin/physiopathology , Risk Factors , Acute Disease , Skin Diseases/therapy , Skin Diseases/physiopathology , Skin Diseases/diagnosis , Skin Diseases/pathology
10.
Cutis ; 113(3): 107-109, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38648591

ABSTRACT

Dermatology electronic consultations (e-consults) placed by primary care providers (PCPs) can increase access to specialty care while reducing wait times and providing accurate clinical outcomes. These e-consults also may reduce barriers for underserved patients who historically have limited access to dermatologic care. Our retrospective chart review examines patient outcomes from a dermatology e-consult program at a tertiary care medical center. E-consults effectively increased access to dermatology care while shortening wait times and reducing health care expenditures.


Subject(s)
Dermatology , Health Services Accessibility , Humans , Retrospective Studies , Male , Primary Health Care , Female , Adult , Middle Aged , Skin Diseases/therapy , Skin Diseases/diagnosis , Remote Consultation , Referral and Consultation/statistics & numerical data
11.
Int J Dermatol ; 63(5): 551-552, 2024 May.
Article in English | MEDLINE | ID: mdl-38581088

ABSTRACT

Dermatological research and education have predominantly focused on lighter skin types in the past, leading to a significant gap in knowledge and understanding of conditions in darker skin types. This has contributed to disparities in the diagnosis and treatment of diseases in patients with skin of color. In the current issue of the Journal, we highlight four papers on the epidemiology and clinics of skin of color patients but also emphasize the importance of education and research in the dermatopathology of SOC patients.


Subject(s)
Dermatology , Skin Pigmentation , Humans , Skin Diseases/diagnosis , Skin Diseases/therapy , Skin Diseases/pathology
13.
Pediatr Ann ; 53(4): e146-e151, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38574070

ABSTRACT

When evaluating pediatric patients of color, it is essential to consider the unique diagnostic and treatment factors that apply to this population. Certain dermatologic conditions are more common in these patients, including postinflammatory hyperpigmentation, pityriasis alba, progressive macular hypomelanosis, tinea capitis, traction alopecia, keloids, hypertrophic scars, pseudofolliculitis barbae, acne keloidalis nuchae, and hidradenitis suppurativa. Furthermore, conditions such as vitiligo are more noticeable in people of color. This can lead to a significantly diminished quality of life, so these conditions should be quickly recognized and treated. Notably, inflammation can be difficult to recognize on the skin of people of color, which can lead to the underestimation of severity as well as inappropriate treatment. Treatment recommendations can also differ based on lifestyle or cultural norms, such as the use of tinted sunscreens and the consideration of hair care practices. Pediatricians should be aware of these conditions and treatment considerations to best treat pediatric patients of color. [Pediatr Ann. 2024;53(4):e146-e151.].


Subject(s)
Dermatology , Hair Diseases , Skin Diseases , Humans , Child , Quality of Life , Skin Pigmentation , Skin Diseases/therapy , Hair Diseases/therapy
17.
Pediatr Dermatol ; 41(3): 480-482, 2024.
Article in English | MEDLINE | ID: mdl-38456206

ABSTRACT

This study focused on evaluating Extension for Community Healthcare Outcomes (ECHO) participating primary care clinician's (PCC's) diagnostic and treatment accuracy of pediatric dermatologic conditions. To evaluate this, pediatric cases presented to Dermatology ECHO by PCCs with questions regarding diagnosis, treatment regimen, or both were analyzed. After PCC case presentation, the hub team of dermatologists facilitated case-based discussion and provided the presenter with mentorship and guidance regarding diagnosis and treatment of their patient.


Subject(s)
Dermatology , Quality Improvement , Skin Diseases , Humans , Dermatology/standards , Child , Skin Diseases/therapy , Skin Diseases/diagnosis , Community Health Services , Male , Female , Pediatrics/standards , Child, Preschool , Primary Health Care , Infant , Adolescent , Quality of Health Care
18.
Adv Skin Wound Care ; 37(4): 1-6, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38506584

ABSTRACT

OBJECTIVE: To explore the experiences of patients with an autoimmune disease during the COVID-19 pandemic. METHODS: A total of 12 patients with autoimmune skin disease who were hospitalized in dermatology wards between 2021 and 2022 participated in this qualitative study. The researchers conducted in-depth, semi-structured interviews, which they analyzed using conventional content analysis. RESULTS: Data analysis revealed three main themes: changes in mental/psychological status, social impacts and financial problems, and physical consequences. These patients reported changes in mental/psychological status as their most important experiences. CONCLUSIONS: During a pandemic, it is important to manage the therapeutic course of patients who are at risk of infection, especially patients with autoimmune skin diseases, via appropriate planning.


Subject(s)
Autoimmune Diseases , COVID-19 , Skin Diseases , Humans , COVID-19/epidemiology , Pandemics , Skin Diseases/therapy , Patients
20.
Adv Drug Deliv Rev ; 208: 115294, 2024 May.
Article in English | MEDLINE | ID: mdl-38527624

ABSTRACT

Genodermatoses represent a large group of inherited skin disorders encompassing clinically-heterogeneous conditions that manifest in the skin and other organs. Depending on disease variant, associated clinical manifestations and secondary complications can severely impact patients' quality of life and currently available treatments are transient and not curative. Multiple emerging approaches using CRISPR-based technologies offer promising prospects for therapy. Here, we explore current advances and challenges related to gene editing in rare skin diseases, including different strategies tailored to mutation type and structural organization of the affected gene, considerations for in vivo and ex vivo applications, the critical issue of delivery into the skin, and immune aspects of therapy. Against the backdrop of a landmark FDA approval for the first re-dosable gene replacement therapy for a rare genetic skin disorder, gene editing approaches are inching closer to the clinics and the possibility of a local permanent cure for patients affected by these disorders.


Subject(s)
Gene Editing , Skin Diseases , Humans , CRISPR-Cas Systems/genetics , Quality of Life , Skin , Skin Diseases/genetics , Skin Diseases/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...